Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TakeAirLabs is the R&D arm associated with Belgian company TakeAir, focused on biotechnology for indoor air quality and healthier built environments. The company develops Biospheric Air Treatment, a ventilation-integrated platform that uses beneficial microorganisms and bio-based components to rebalance indoor microbial ecosystems, reduce pathogen dominance, and support occupant well-being. Its technology is positioned for commercial buildings rather than traditional therapeutic drug development, combining microbiology, ventilation engineering, and data-driven building management. Public materials describe work on bioremediation and seaweed-derived pathogen control approaches, with research support from Avecom and connections to Ghent University expertise. Overall, TakeAirLabs appears to be a health-adjacent environmental biotech company rather than a conventional pharma or therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TakeAirLabs.